Given the increased risk of renal dysfunction in COVID-19 and the worsening of conditions in patients with chronic kidney or diabetic kidney disease, BCP may be a valuable candidate in preventing renal dysfunction in patients with COVID-19. This evidence concerns the gene OPN1SW and Abnormal renal physiology.